FY2025 · period end Dec '25 · from the 10-K filed Feb 13, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| Gross Profit | $6.80B | $6.54B | $5.98B | $5.63B | $5.47B |
| Operating Income | — | — | — | — | — |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B |
| Total Liabilities | $12.07B | $9.47B | $9.29B | $10.52B | $9.36B |
| Stockholders' Equity | $3.42B | $4.84B | $4.99B | $4.40B | $4.54B |
| Cash & Equivalents | — | — | — | — | — |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B |
| Capital Expenditures | $0.62B | $0.66B | $0.73B | $0.59B | $0.48B |
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 71.8% | 70.6% | 70.0% | 69.6% | 70.4% |
| Operating Margin | 0.3% | 0.3% | 0.3% | 0.3% | — |
| Net Margin | 0.3% | 0.3% | 0.3% | 0.3% | 26.2% |
| Return on Equity | 66.0% | 50.9% | 49.9% | 47.3% | 44.8% |
| Return on Assets | 18.0% | 17.4% | 16.0% | 14.7% | 14.7% |
| Debt / Equity | 2.71× | 1.38× | 1.32× | 1.80× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling Zoetis Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ZTS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ZTS and publish the result to your public profile.
Ask about Zoetis Inc.
Continue in Workspace — cited answers on ZTS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001555280-26-000040 | Jun 30, 2026 | Aug 6, 2026 | Aug 6, 2026 22:32 UTC | EDGAR |
| 10-Q | 0001555280-26-000024 | Mar 31, 2026 | May 7, 2026 | May 8, 2026 00:26 UTC | EDGAR |
| 10-K | 0001555280-26-000011 | Dec 31, 2025 | Feb 12, 2026 | Feb 13, 2026 02:49 UTC | EDGAR |
| 10-Q | 0001555280-25-000274 | Sep 30, 2025 | Nov 4, 2025 | Nov 5, 2025 01:02 UTC | EDGAR |
| 10-Q | 0001555280-25-000261 | Jun 30, 2025 | Aug 5, 2025 | Aug 5, 2025 21:58 UTC | EDGAR |
| 10-Q | 0001555280-25-000203 | Mar 31, 2025 | May 6, 2025 | May 6, 2025 21:29 UTC | EDGAR |
| 10-K | 0001555280-25-000102 | Dec 31, 2024 | Feb 13, 2025 | Feb 14, 2025 00:51 UTC | EDGAR |
| 10-Q | 0001555280-24-000332 | Sep 30, 2024 | Nov 4, 2024 | Nov 4, 2024 23:52 UTC | EDGAR |
| 10-Q | 0001555280-24-000299 | Jun 30, 2024 | Aug 6, 2024 | Aug 6, 2024 20:41 UTC | EDGAR |
| 10-Q | 0001555280-24-000249 | Mar 31, 2024 | May 2, 2024 | May 2, 2024 20:26 UTC | EDGAR |
| 10-K | 0001555280-24-000143 | Dec 31, 2023 | Feb 13, 2024 | Feb 14, 2024 00:33 UTC | EDGAR |
| 10-Q | 0001555280-23-000247 | Sep 30, 2023 | Nov 2, 2023 | Nov 2, 2023 19:45 UTC | EDGAR |
Direct links to SEC EDGAR. ZTS has additional filings available on the SEC site.
6 numbers Zoetis Inc. later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q1 2025
Major restatementwas$587M
Revised down in a 10-Q. Any P/OCF built on the original was 14.0% too low.
Net Income (Loss) Attributable to Parent·Q1 2025
Notable restatementwas$631M
Revised down in a 10-Q. Any P/E built on the original was 4.8% too low.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q1 2025
Notable restatementwas$810M
Revised down in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q2 2025
Notable restatementwas$1.1B
Revised up in a 10-Q. Any P/OCF built on the original was 4.2% too high.
Stockholders' Equity Attributable to Parent·As of Dec 31, 2025
Notable restatementwas$3.3B
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q2 2025
Minor restatementwas$718M
Revised up in a 10-Q. Any P/E built on the original was 1.1% too high.
ZTS is not the only one.
See every restatement we've found across the market — or get an alert the next time ZTS revises a number.
Restatements are detected by comparing every vintage of a fact across all of Zoetis Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ZTS's most significant revisions, and a figure absent from it has not been certified as unrevised.
